//
sign in
Profile
by @danabra.mov
Profile
by @dansshadow.bsky.social
Profile
by @jimpick.com
AviHandle
by @danabra.mov
AviHandle
by @dansshadow.bsky.social
AviHandle
by @katherine.computer
EventsList
by @katherine.computer
ProfileHeader
by @dansshadow.bsky.social
ProfileHeader
by @danabra.mov
ProfileMedia
by @danabra.mov
ProfilePlays
by @danabra.mov
ProfilePosts
by @danabra.mov
ProfilePosts
by @dansshadow.bsky.social
ProfileReplies
by @danabra.mov
Record
by @atsui.org
Skircle
by @danabra.mov
StreamPlacePlaylist
by @katherine.computer
+ new component
Profile
Loading...
Putting public health needs at the centre of antibiotic drug development to address the crisis of antimicrobial resistance (AMR). https://gardp.org/this-is-big/
Global Antibiotic R&D Partnership (GARDP)









Loading...
💊 Join an information session on the new Community of Practice established by @who.int as part of the SECURE initiative to support countries introducing a new antibiotic for the first time. 📅 24 June | 🕛 12:00–13:00 CET 👉 us06web.zoom.us/webinar/regi...
🤝 GARDP is proud to join forces with @dndi.org and @mmv.org to strengthen coordination, share expertise and accelerate the development of life-saving treatments for people worldwide. 📄 Learn more: gardp.org/dndi-gardp-a...
#PressRelease @dndi.org, @gardp.bsky.social and MMV are joining forces to strengthen collaboration, maximize the impact of global health R&D, and accelerate the development of life-saving treatments. Read the press release: bit.ly/4fo8xu0
As global health budgets shrink, three Geneva-based non-profit R&D groups — @dndi.org, @gardp.bsky.social. & @mmv.org — are joining forces to accelerate lifesaving medicines for malaria, NCDs & antimicrobial resistance. ✍️ @kerrycullinan.bsky.social 📰➡️ healthpolicy-watch.news/non-profit-r...
📊 Poll answer: D) All of the above. Pooled procurement can help reduce medicine shortages, strengthen supply security, improve access and make healthcare budgets go further. 🎥 Curious how it works? Watch our latest REVIVE explainer video: revive.gardp.org/resource/poo...
“What we’re trying to show is that it's not just about our organisations: it's about this model of working together,” says Luis Pizarro our Executive Director in @genevasolutions.bsky.social on the strategic agreement signed by @gardp.bsky.social, @mmv.org, DNDi. genevasolutions.news/global-healt...
🔬Of 10,000 compounds entering early antibiotic research, only 1 or 2 will ever reach patients. Can AI improve those odds? A new #REVIVE Antimicrobial Viewpoint explores how AI is reshaping antibiotic discovery & why innovation alone isn't enough to tackle #AMR. 📖 revive.gardp.org/ai-is-revivi...
Great initiative from the ADVANCE-ID Network. Looking forward to the webinar and learning more about the upcoming open call. 👇
Which of these can pooled procurement help reduce? A) Medicine shortages B) Costs C) Procurement risks D) All of the above
📍 At SADI 2026 in Argentina, GARDP joined PAHO, academic experts and health leaders to discuss financing and access to high-cost infectious disease therapies. The session highlighted the need to pair access with stewardship, surveillance and evidence generation.
16m
1h
10d
8d